Targeting epigenetics and lncRNAs in liver disease: From mechanisms to therapeutics

Xiao-Fei Peng1, Shi-Feng Huang2, Ling-Juan Chen3

  • 1Department of General Surgery, Qingyuan People's Hospital, The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan 511518, Guangdong Province, China.

Pharmacological Research
|August 26, 2021
PubMed

Insights

Epigenetic mechanisms like RNA methylation and histone modification are key drivers of liver disease. Targeting these epigenetic regulators offers promising therapeutic strategies for hepatic diseases.

Area of Science:

  • Molecular Biology
  • Epigenetics
  • Hepatology

Background:

  • Aberrant transcriptional regulation significantly impacts liver disease onset and progression.
  • Epigenetics, encompassing RNA/DNA methylation, histone modification, and ncRNA targeting, plays a crucial role in both healthy and diseased liver cells.
  • Liver disease research increasingly focuses on its strong epigenetic component, transforming epigenetics from a basic biological phenomenon to a disease research focus.

Purpose of the Study:

  • To review and synthesize current knowledge on five key epigenetic processes in hepatic diseases: RNA methylation, DNA methylation, histone methylation, microRNAs (miRNAs), and long non-coding RNAs (lncRNAs).
  • To discuss the therapeutic potential of targeting epigenetic regulators, such as m6A-related factors, for liver disease prevention and treatment.
  • To provide a perspective on identifying novel hepatic biomarkers and therapeutic targets within the epigenetics field for precision medicine.

Main Methods:

  • Literature review and synthesis of existing studies on epigenetic mechanisms in liver disease.
  • Discussion of interconnectedness and interdependence of different epigenetic processes.
  • Analysis of therapeutic implications and future research directions.

Main Results:

  • Epigenetic processes are fundamental to liver biology and disease pathogenesis.
  • Inhibitors of epigenetic regulators show potential as therapeutic agents for liver conditions.
  • The review consolidates understanding of RNA methylation, DNA methylation, histone methylation, miRNAs, and lncRNAs in hepatic diseases.

Conclusions:

  • Epigenetic dysregulation is a critical factor in liver disease.
  • Targeting epigenetic mechanisms presents a promising avenue for novel therapeutic strategies and biomarker discovery in hepatology.
  • This review highlights the transformative role of epigenetics in advancing precision research and treatment for liver diseases.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.1K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
14.3K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
36
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
34
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.5K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.7K